Detalhe da pesquisa
1.
Are malaria transmission-blocking vaccines acceptable to high burden communities? Results from a mixed methods study in Bo, Sierra Leone.
Malar J
; 20(1): 183, 2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849572